Alphagan, Xalatan Among Drugs Costing Seniors More.

Review of Optometry,  July, 2001  

• E-mail
• Print
• Link

The 50 most heavily prescribed drugs for seniors rose in price, on average, at more than twice the rate of inflation over the past year, reports a new study from the consumer health organization Families USA. The prices of these 50 drugs increased on average 6.1%, although the rate of inflation (excluding energy) was 2.7% during 2000.

The report says that more than a third (18 of 50) of the most-prescribed drugs for seniors rose in price at least three times the rate of inflation. Among the drugs were two for eye care: Alphagan (brimonidine), which rose 8.4 times ...

Read the rest of this article with a Free Trial at HighBeam Research.